An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score

被引:905
|
作者
Frank, I [1 ]
Blute, ML
Cheville, JC
Lohse, CM
Weaver, AL
Zincke, H
机构
[1] Mayo Med Sch & Mayo Clin, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Med Sch & Mayo Clin, Dept Pathol, Rochester, MN USA
[3] Mayo Med Sch & Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源
JOURNAL OF UROLOGY | 2002年 / 168卷 / 06期
关键词
carcinoma; renal cell; treatment outcome; survival; nephrectomy;
D O I
10.1016/S0022-5347(05)64153-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Currently outcome prediction in renal cell carcinoma is largely based on pathological stage and tumor grade. We developed an outcome prediction model for patients treated with radical nephrectomy for clear cell renal cell carcinoma, which was based on all available clinical and pathological features significantly associated with death from renal cell carcinoma. Materials and Methods: We identified 1,801 adult patients with unilateral clear cell renal cell carcinoma treated with radical nephrectomy between 1970 and 1998. Clinical features examined included age, sex, smoking history, and signs and symptoms at presentation. Pathological features examined included 1997 TNM stage, tumor size, nuclear grade, histological tumor necrosis, sarcomatoid component, cystic architecture, multifocality and surgical margin status. Cancer specific survival was estimated using the Kaplan-Meier method. Cox proportional hazards regression models were used to test associations between features studied and outcome. The selection of features included in the multivariate model was validated using bootstrap methodology. Results: Mean followup was 9.7 years (range 0.1 to 3 1). Estimated cancer specific survival rates at 1, 3, 5, 7 and 10 years were 86.6%, 74.0%, 68.7%, 63.8% and 60.0%, respectively. Several features were multivariately associated with death from clear cell renal cell carcinoma, including 1997 TNM stage (p <0.001), tumor size 5 cm. or greater (p <0.001), nuclear grade (p <0.001) and histological tumor necrosis (p <0.001). Conclusions: In patients with clear cell renal cell carcinoma 1997 TNM stage, tumor size, nuclear grade and histological tumor necrosis were significantly associated with cancer specific survival. We present a scoring system based on these features that can be used to predict outcome.
引用
收藏
页码:2395 / 2400
页数:6
相关论文
共 50 条
  • [21] An improved clear cell renal cell carcinoma stage prediction model based on gene sets
    Li, Fangjun
    Yang, Mu
    Li, Yunhe
    Zhang, Mingqiang
    Wang, Wenjuan
    Yuan, Dongfeng
    Tang, Dongqi
    [J]. BMC BIOINFORMATICS, 2020, 21 (01)
  • [22] An improved clear cell renal cell carcinoma stage prediction model based on gene sets
    Fangjun Li
    Mu Yang
    Yunhe Li
    Mingqiang Zhang
    Wenjuan Wang
    Dongfeng Yuan
    Dongqi Tang
    [J]. BMC Bioinformatics, 21
  • [23] Prognostic score for patients with localized renal cell carcinoma treated by nephrectomy
    Nativ, O
    Sabo, E
    Madeb, R
    Halachmi, S
    Madjar, S
    Moskovitz, B
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (01): : 24 - 27
  • [24] EPIGENETICALLY REPRESSED MIRNAS AS PREDICTORS OF TUMOR RECURRENCE IN CLEAR CELL RENAL CELL CARCINOMA PATIENTS FOLLOWING RADICAL NEPHRECTOMY
    Liep, Julia
    Wotschofsky, Zofia
    Miller, Kurt
    Jung, Klaus
    Busch, Jonas
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E194 - E194
  • [25] ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy?
    Xing, Zhuo
    Li, Yuan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (5) : 3556 - 3557
  • [26] ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy?
    Zhuo Xing
    Yuan Li
    [J]. Annals of Surgical Oncology, 2024, 31 : 3556 - 3557
  • [27] CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma
    Natalie L. Demirjian
    Bino A. Varghese
    Steven Y. Cen
    Darryl H. Hwang
    Manju Aron
    Imran Siddiqui
    Brandon K. K. Fields
    Xiaomeng Lei
    Felix Y. Yap
    Marielena Rivas
    Sharath S. Reddy
    Haris Zahoor
    Derek H. Liu
    Mihir Desai
    Suhn K. Rhie
    Inderbir S. Gill
    Vinay Duddalwar
    [J]. European Radiology, 2022, 32 : 2552 - 2563
  • [28] CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma
    Demirjian, Natalie L.
    Varghese, Bino A.
    Cen, Steven Y.
    Hwang, Darryl H.
    Aron, Manju
    Siddiqui, Imran
    Fields, Brandon K. K.
    Lei, Xiaomeng
    Yap, Felix Y.
    Rivas, Marielena
    Reddy, Sharath S.
    Zahoor, Haris
    Liu, Derek H.
    Desai, Mihir
    Rhie, Suhn K.
    Gill, Inderbir S.
    Duddalwar, Vinay
    [J]. EUROPEAN RADIOLOGY, 2022, 32 (04) : 2552 - 2563
  • [29] A protocol for extended lymph node dissection using primary tumor pathologic features for patients treated with radical nephrectomy for clear cell renal cell carcinoma
    Blute, ML
    Leibovich, BC
    Cheville, JC
    Lohse, CM
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 467 - 467
  • [30] Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy
    Tanaka, Ryuma
    Hatakeyama, Shingo
    Miura, Hikari
    Hamaya, Tomoko
    Yoneyama, Takahiro
    Ohyama, Chikara
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (10) : 1235 - 1237